| Patent | Date |
|---|
Formulations of Nonopioid and Confined Opioid Analgesics
App 20170014348 - Breitenbach; Joerg ; et al. | 2017-01-19 |
Salts Of Fenofibric Acid And Pharmaceutical Formulations Thereof
App 20140187561 - Cink; Russell Drew ; et al. | 2014-07-03 |
Solid Pharmaceutical Dosage Form
App 20140179721 - Rosenberg; Joerg ; et al. | 2014-06-26 |
Self-Emulsifying Active Ingredient Formulation and the Use of This Formulation
App 20140135388 - BERNDL; Gunther ; et al. | 2014-05-15 |
Formulations Of Nonopioid And Confined Opioid Analgesics
App 20130344143 - Rosenberg; Joerg ; et al. | 2013-12-26 |
Solid Pharmaceutical Dosage Form
App 20130072508 - Rosenberg; Joerg ; et al. | 2013-03-21 |
Solid pharmaceutical dosage form
Grant 8,399,015 - Rosenberg , et al. March 19, 2 | 2013-03-19 |
Solid pharmaceutical dosage formulation
Grant 8,377,952 - Rosenberg , et al. February 19, 2 | 2013-02-19 |
Salts Of Fenofibric Acid And Pharmaceutical Formulations Thereof
App 20130018101 - Cink; Russell Drew ; et al. | 2013-01-17 |
Solid pharmaceutical dosage form
Grant 8,333,990 - Rosenberg , et al. December 18, 2 | 2012-12-18 |
Solid pharmaceutical dosage form
Grant 8,309,613 - Rosenberg , et al. November 13, 2 | 2012-11-13 |
Solid pharmaceutical dosage form
Grant 8,268,349 - Rosenberg , et al. September 18, 2 | 2012-09-18 |
Solid Pharmaceutical Dosage Form
App 20120202858 - Rosenberg; Joerg ; et al. | 2012-08-09 |
Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt Or Derivative Thereof
App 20120178808 - Rosenberg; Joerg ; et al. | 2012-07-12 |
Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt Or Derivative Thereof
App 20120046360 - Rosenberg; Joerg ; et al. | 2012-02-23 |
Solid Pharmaceutical Dosage Form
App 20120022089 - Rosenberg; Joerg ; et al. | 2012-01-26 |
Solid pharmaceutical dosage form
Grant 8,025,899 - Berndl , et al. September 27, 2 | 2011-09-27 |
Formulations Of Nonopioid And Confined Opioid Analgesics
App 20110229526 - Rosenberg; Joerg ; et al. | 2011-09-22 |
Solid Pharmaceutical Dosage Form
App 20110015216 - Berndl; Gunther ; et al. | 2011-01-20 |
Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt or Derivative Thereof
App 20100081715 - Rosenberg; Joerg ; et al. | 2010-04-01 |
Salts Of Fenofibric Acid And Pharmaceutical Formulations Thereof
App 20090263477 - Cink; Russell D. ; et al. | 2009-10-22 |
Rate-controlled Particles
App 20090148531 - Hantke; Thomas ; et al. | 2009-06-11 |
Formulations Of Nonopioid And Confined Opioid Analgesics
App 20090022798 - Rosenberg; Joerg ; et al. | 2009-01-22 |
Solid Pharmaceutical Dosage Formulation
App 20080299203 - Rosenberg; Joerg ; et al. | 2008-12-04 |
Solid Pharmaceutical Dosage Formulations
App 20080181948 - Berndl; Gunther ; et al. | 2008-07-31 |
Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
App 20080051411 - Cink; Russell Drew ; et al. | 2008-02-28 |
Solid Pharmaceutical Dosage Form
App 20070249643 - Rosenberg; Joerg ; et al. | 2007-10-25 |
Solid Pharmaceutical Form Comprising and Ltb4 Antagonist
App 20070237823 - Bock; Thomas ; et al. | 2007-10-11 |
Stable dosage forms containing ubiquinones
Grant 7,273,624 - Rosenberg , et al. September 25, 2 | 2007-09-25 |
Salts of fenofibric acid and pharmaceutical formulations thereof
Grant 7,259,186 - Cink , et al. August 21, 2 | 2007-08-21 |
Pharmaceutical Compositions
App 20070077307 - Rosenberg; Joerg ; et al. | 2007-04-05 |
Pharmaceutical compositions
App 20070049636 - Rosenberg; Joerg ; et al. | 2007-03-01 |
Pharmaceutical Compositions
App 20070048384 - Rosenberg; Joerg ; et al. | 2007-03-01 |
Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier
App 20060257470 - Rosenberg; Joerg ; et al. | 2006-11-16 |
Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
App 20060134196 - Rosenberg; Joerg ; et al. | 2006-06-22 |
Salts of fenofibric acid and pharmaceutical formulations thereof
App 20050148594 - Cink, Russell Drew ; et al. | 2005-07-07 |
Solid pharmaceutical dosage formulation
App 20050143404 - Rosenberg, Joerg ; et al. | 2005-06-30 |
Solid pharmaceutical dosage form
App 20050084529 - Rosenberg, Joerg ; et al. | 2005-04-21 |
Solid pharmaceutical dosage form
App 20050048112 - Breitenbach, Jorg ; et al. | 2005-03-03 |
Multiphase active ingredient-containing formulations
Grant 6,787,157 - Rosenberg , et al. September 7, 2 | 2004-09-07 |
Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
App 20040029892 - Rosenberg, Joerg ; et al. | 2004-02-12 |
Stable dosage forms containing ubiquinones
App 20040014817 - Rosenberg, Joerg ; et al. | 2004-01-22 |
Use of lipids as adjuvents in the production of solid medicinal forms by the melt extrusion process
Grant 6,387,401 - Rosenberg , et al. May 14, 2 | 2002-05-14 |
Slow-release matrix pellets and the production thereof
Grant 6,290,990 - Grabowski , et al. September 18, 2 | 2001-09-18 |
Use Of Lipids As Adjuvents In The Production Of Solid Medicinal Forms By The Melt Extrusion Process
App 20010007664 - ROSENBERG, JOERG ; et al. | 2001-07-12 |
Process for producing solid dosage forms by extrusion
Grant 6,221,368 - Breitenbach , et al. April 24, 2 | 2001-04-24 |
Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt
Grant 6,187,342 - Zeidler , et al. February 13, 2 | 2001-02-13 |
Production of lenticular tablets by melt calendering
Grant 6,132,659 - Rosenberg , et al. October 17, 2 | 2000-10-17 |
Method of producing multi-layer medicaments in solid form for oral or rectal administration
Grant 6,120,802 - Breitenbach , et al. September 19, 2 | 2000-09-19 |
Transparent rapid release compositions of non-steroidal analgesics
Grant 6,063,821 - Breitenbach , et al. May 16, 2 | 2000-05-16 |
Production of solid drug forms
Grant 6,051,253 - Zettler , et al. April 18, 2 | 2000-04-18 |
Process and apparatus for the production of divisible tablets
Grant 6,009,690 - Rosenberg , et al. January 4, 2 | 2000-01-04 |
Process for producing solid drug forms having at least two phases
Grant 6,001,391 - Zeidler , et al. December 14, 1 | 1999-12-14 |
Preparation of salts of pharmaceutical active substances which have acidic groups
Grant 5,969,181 - Breitenbach , et al. October 19, 1 | 1999-10-19 |
Solid active extrusion compound preparations containing low-substituted hydroxypropylcellulose
Grant 5,939,099 - Grabowski , et al. August 17, 1 | 1999-08-17 |
Production of covered tablets
Grant 5,897,910 - Rosenberg , et al. April 27, 1 | 1999-04-27 |
The production of active substance compositions in the form of a solid solution of the active substance in a polymer matrix, and active substance compositions produced by this process
Grant 5,741,519 - Rosenberg , et al. April 21, 1 | 1998-04-21 |
Compositions which contain active substances and are in the form of solid particles
Grant 5,641,516 - Grabowski , et al. June 24, 1 | 1997-06-24 |
Preparation of colloidal aqueous solutions of active substances of low solubility
Grant 5,626,864 - Rosenberg , et al. May 6, 1 | 1997-05-06 |
Preparation of an active substance solution which can be sterilized by filtration
Grant 5,432,196 - Rosenberg , et al. July 11, 1 | 1995-07-11 |
Method for improving delivery and reducing toxicity of biologically active substances using novel .alpha.-amino dicarboxylic acid derivatives
Grant 5,370,877 - Rosenberg , et al. December 6, 1 | 1994-12-06 |
| 